Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEVEN DUNDER

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1346264546
CMS profile
288332
Location
LINCOLN, NE

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$2,300.74

133 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,124.96 130
Education $175.78 3

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 3; records 101–133 of 133 matching records. This page contains 33 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

STEVEN DUNDER

NPI 1346264546 · CMS profile ID 288332

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

LINCOLN, NE

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–133 of 133 matching records. This page contains 33 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1346264546?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
STEVEN DUNDER, NPI 1346264546, CMS profile ID 288332. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–133 of 133 matching records. This page contains 33 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1346264546?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). STEVEN DUNDER, NPI 1346264546, CMS profile ID 288332. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–133 of 133 matching records. This page contains 33 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1346264546?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
STEVEN DUNDER, NPI 1346264546, CMS profile ID 288332, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–133 of 133 matching records. This page contains 33 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1346264546?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

133 matching records · $2,300.74 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 133 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–133 of 133.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Ipsen Biopharmaceuticals, Inc $19.2303/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045429447 CMS
Seagen Inc. $21.2303/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995706545 CMS
Pharmacyclics LLC, An AbbVie Company $15.8203/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998285001 CMS
Eisai Inc. $13.3003/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023333661 CMS
Foundation Medicine, Inc. $20.6503/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058794115 CMS
Eisai Inc. $14.7903/07/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023333673 CMS
Eisai Inc. $17.6503/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023333663 CMS
Eisai Inc. $15.7703/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023333667 CMS
Janssen Biotech, Inc. $18.2803/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988246873 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.7203/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000501743 CMS
AstraZeneca Pharmaceuticals LP $19.1002/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015825189 CMS
Celgene Corporation $9.2802/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016274411 CMS
E.R. Squibb & Sons, L.L.C. $20.4602/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016274407 CMS
Novartis Pharmaceuticals Corporation $14.9202/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991637569 CMS
Seagen Inc. $14.8502/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995706515 CMS
Eisai Inc. $12.7402/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023333665 CMS
Karyopharm Therapeutics Inc. $16.3902/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056909327 CMS
Myriad Genetic Laboratories, Inc. $13.6302/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059771993 CMS
Seagen Inc. $12.0002/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995706573 CMS
Organon LLC $18.0602/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046788063 CMS
PFIZER INC. $12.6802/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049559082 CMS
AstraZeneca Pharmaceuticals LP $17.3502/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011962050 CMS
Celgene Corporation $14.3002/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016274401 CMS
CTI BioPharma Corp. $16.4801/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039696693 CMS
Gilead Sciences, Inc. $14.2701/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026016009 CMS
E.R. Squibb & Sons, L.L.C. $20.5701/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016274375 CMS
TerSera Therapeutics LLC $22.9401/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052425111 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.5101/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055381477 CMS
Adaptive Biotechnologies Corporation $18.4901/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022975985 CMS
SERVIER PHARMACEUTICALS LLC $19.6901/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055094217 CMS
Janssen Biotech, Inc. $18.7801/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988246885 CMS
Daiichi Sankyo Inc. $12.9701/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006372813 CMS
Novartis Pharmaceuticals Corporation $18.0201/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991637557 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,039.50 129
PY2020 $2,973.47 65
PY2021 $1,872.61 114
PY2022 $4,175.13 140
PY2023 $2,300.74 133
PY2024 $2,326.07 143
PY2025 $3,063.62 140

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $43,233.53 3
PY2023 Principal investigator $34,405.19 2
PY2022 Principal investigator $110,335.39 9
PY2021 Principal investigator $147,981.66 15
PY2020 Principal investigator $188,167.75 37
PY2019 Principal investigator $67,872.70 25

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Mirati Therapeutics, Inc. $21,852.00 06/18/2024 Non-covered Recipient Entity
Southeast Nebraska Cancer Center
A Randomized Phase 3 Study of MRTX849 in Combination With Cetuximab Versus Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation With Disease Progression On or After Standard First-Line Therapy No dispute reported 06/30/2026 1124763860
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,519.77 06/05/2024 Non-covered Recipient Entity
CANCER PARTNERS OF NEBRASKA PC
A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Study to Determine the Efficacy of Adjuvant Durvalumab in Combination with Platinum-based Chemotherapy in Completely Resected Stage II-III NSCLC MeRmaiD 1 No dispute reported 06/30/2026 1110842333
Principal investigator 1 AstraZeneca UK Limited $15,861.76 04/18/2024 Non-covered Recipient Entity
CANCER PARTNERS OF NEBRASKA PC
A Phase 2 Open-label, Multicenter, Randomized, Multidrug Platform Study of Durvalumab (MEDI4736) Alone or in Combination with Novel Agents in Subjects with Locally Advanced, Unresectable, Stage III Non-small Cell Lung Cancer (COAST) No dispute reported 06/30/2026 1110838664